SSRETAIL share price & results

SSRETAIL· Consumer Services· Consumer Discretionary

Results to
Jun 2025
Ownership as of
Sept 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue498 ₹ crore—Quarterly, as filedQuarter to Jun 2025Revenue from operations as filed. No quarter a year earlier is in the series, so no change is shown.
Operating margin6.0 %—Operating profit / revenueQuarter to Jun 2025For the quarter; a change is in percentage points. No quarter a year earlier is in the series, so no change is shown.
Net profit15.0 ₹ crore—Quarterly, as filedQuarter to Jun 2025Profit after tax as filed. No quarter a year earlier is in the series, so no change is shown.
Return on equityUnavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin0.18 %—Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2025

Price

₹691.95 −0.04% · −₹0.25

Last close 13 Oct 2026 · NSE · INR

Performance −7.6% YTD

₹700₹750₹800SeptOct

YTD: ₹748.8 on 23 Sept 2026 → ₹691.95. High ₹811.8 (24 Sept 2026), low ₹677.15 (5 Oct 2026).

Previous close
₹692.2
Market cap
₹5.1k Cr
52-week range
₹677.15 – ₹811.8
Price to earnings (FY ending Mar 2026)
85.75×
Return on equity (FY ending Mar 2026)
26.55%

Overview

Symbol
NSE:SSRETAIL
Industry
Consumer Discretionary
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for SSRETAIL

Free account: one company. Everything above stays public.

Write why you follow SSRETAIL and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.